Morgan Stanley Maintains Equal-Weight on Kyndryl Hldgs, Lowers Price Target to $13

Benzinga Newsdesk www.benzinga.com Neutral 64.8%

Neg 0% Neu 64.8% Pos 0%

Morgan Stanley analyst James Faucette maintains Kyndryl Hldgs (NYSE:KD) with a Equal-Weight and lowers the price target from $28 to $13.